News
Portman Holdings, LLC has delivered the first portion of its major Philadelphia 1.9 million square foot industrial campus.
13d
MyChesCo on MSNFrontage Laboratories Opens State-of-the-Art CRDMO Facility in ExtonFrontage Laboratories, Inc. hosted a grand opening event to unveil its newest Contract Research, Development, and ...
Takeda's AI-powered "returning to growth" program has improved profit margins, leading to upgraded FY2024 guidance and a JPY100 billion share buyback program. Takeda's Rusfertide and Protagonist's ...
The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...
Global biopharmaceutical company Takeda has launched an innovation capability centre (ICC) in Bengaluru, India, joining existing facilities in Slovakia and Mexico. The Bengaluru ICC will focus on ...
Following a series of layoff rounds this year, Takeda is once again pruning its headcount in the Bay State. Takeda is laying off dozens of employees in Massachusetts, according to a Worker ...
Clarence H. Walker, 97, of Exton, PA, passed away on Sunday, August 25, 2024. He was the son of the late James H. and Roxie (nee Dexter) Walker, and the youngest of 6 children. Survivors ...
EXTON, Pa. (CBS) -- The Exton Square Mall Spring Carnival is canceled after the carnival company's permit was revoked following a large crowd control issue Saturday night, West Whiteland Police ...
Merrill Ernest Conner, 94, of Exton, PA passed away on May 4, 2024 at his residence. Born in Hamburg, NJ, Merrill was the son of the late Ernest and Estella (Peterson) Conner. He was the husband ...
Takeda has made some cuts to its clinical-phase pipeline, hacking off midphase programs and early-stage prospects as part of a push to focus on its most promising candidates. Let’s start in phase 2.
Takeda’s vision of becoming a leader in oncology ran into more trouble Thursday when the drugmaker axed (PDF) a midphase immunocytokine and three early-stage CAR-T cell therapy prospects from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results